nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Disulfiram—alcohol dependence	0.232	0.584	CbGbCtD
Avanafil—CYP3A4—Citalopram—alcohol dependence	0.166	0.416	CbGbCtD
Avanafil—Seasonal allergy—Naltrexone—alcohol dependence	0.0194	0.0345	CcSEcCtD
Avanafil—Rhinitis seasonal—Naltrexone—alcohol dependence	0.0186	0.0331	CcSEcCtD
Avanafil—Angina unstable—Naltrexone—alcohol dependence	0.0161	0.0286	CcSEcCtD
Avanafil—Upset stomach—Disulfiram—alcohol dependence	0.0133	0.0237	CcSEcCtD
Avanafil—Abdominal pain lower—Naltrexone—alcohol dependence	0.0128	0.0228	CcSEcCtD
Avanafil—Sinus headache—Naltrexone—alcohol dependence	0.0125	0.0222	CcSEcCtD
Avanafil—Seasonal allergy—Citalopram—alcohol dependence	0.0123	0.0219	CcSEcCtD
Avanafil—Muscle tightness—Citalopram—alcohol dependence	0.0123	0.0219	CcSEcCtD
Avanafil—Rhinitis seasonal—Citalopram—alcohol dependence	0.0118	0.021	CcSEcCtD
Avanafil—Penis disorder—Citalopram—alcohol dependence	0.0118	0.021	CcSEcCtD
Avanafil—Blood urine present—Citalopram—alcohol dependence	0.0109	0.0195	CcSEcCtD
Avanafil—Sinus congestion—Naltrexone—alcohol dependence	0.00818	0.0145	CcSEcCtD
Avanafil—Sinus headache—Citalopram—alcohol dependence	0.00791	0.0141	CcSEcCtD
Avanafil—Deep vein thrombosis—Naltrexone—alcohol dependence	0.00669	0.0119	CcSEcCtD
Avanafil—Upset stomach—Naltrexone—alcohol dependence	0.00621	0.011	CcSEcCtD
Avanafil—Pruritus genital—Citalopram—alcohol dependence	0.00618	0.011	CcSEcCtD
Avanafil—Nephrolithiasis—Acamprosate—alcohol dependence	0.00535	0.00951	CcSEcCtD
Avanafil—Priapism—Citalopram—alcohol dependence	0.00534	0.00949	CcSEcCtD
Avanafil—Abdominal discomfort—Disulfiram—alcohol dependence	0.00525	0.00934	CcSEcCtD
Avanafil—Sinus congestion—Citalopram—alcohol dependence	0.00518	0.00921	CcSEcCtD
Avanafil—Blood glucose increased—Citalopram—alcohol dependence	0.00504	0.00896	CcSEcCtD
Avanafil—Rhinorrhoea—Naltrexone—alcohol dependence	0.00502	0.00893	CcSEcCtD
Avanafil—Gout—Acamprosate—alcohol dependence	0.00461	0.00819	CcSEcCtD
Avanafil—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00451	0.00801	CcSEcCtD
Avanafil—Oropharyngeal pain—Naltrexone—alcohol dependence	0.00448	0.00796	CcSEcCtD
Avanafil—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.0043	0.00765	CcSEcCtD
Avanafil—Deep vein thrombosis—Citalopram—alcohol dependence	0.00424	0.00754	CcSEcCtD
Avanafil—Blood pressure increased—Naltrexone—alcohol dependence	0.00407	0.00724	CcSEcCtD
Avanafil—PDE5A—forebrain—alcohol dependence	0.00406	0.122	CbGeAlD
Avanafil—Upset stomach—Citalopram—alcohol dependence	0.00394	0.007	CcSEcCtD
Avanafil—Electrocardiogram abnormal—Citalopram—alcohol dependence	0.00394	0.007	CcSEcCtD
Avanafil—Diabetes mellitus—Acamprosate—alcohol dependence	0.00359	0.00638	CcSEcCtD
Avanafil—PDE5A—cardiovascular system—alcohol dependence	0.00343	0.103	CbGeAlD
Avanafil—Nasal congestion—Naltrexone—alcohol dependence	0.00324	0.00577	CcSEcCtD
Avanafil—Nephrolithiasis—Citalopram—alcohol dependence	0.00321	0.0057	CcSEcCtD
Avanafil—Rhinorrhoea—Citalopram—alcohol dependence	0.00318	0.00566	CcSEcCtD
Avanafil—Hot flush—Naltrexone—alcohol dependence	0.00316	0.00562	CcSEcCtD
Avanafil—Menopausal symptoms—Naltrexone—alcohol dependence	0.00313	0.00557	CcSEcCtD
Avanafil—PDE5A—gonad—alcohol dependence	0.00311	0.0935	CbGeAlD
Avanafil—Pain in extremity—Naltrexone—alcohol dependence	0.00296	0.00525	CcSEcCtD
Avanafil—Blood creatinine increased—Acamprosate—alcohol dependence	0.00293	0.0052	CcSEcCtD
Avanafil—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00286	0.00508	CcSEcCtD
Avanafil—PDE5A—digestive system—alcohol dependence	0.00285	0.0855	CbGeAlD
Avanafil—Breast disorder—Acamprosate—alcohol dependence	0.00282	0.00502	CcSEcCtD
Avanafil—Somnolence—Disulfiram—alcohol dependence	0.00277	0.00492	CcSEcCtD
Avanafil—Gastritis—Acamprosate—alcohol dependence	0.00276	0.00491	CcSEcCtD
Avanafil—Gout—Citalopram—alcohol dependence	0.00276	0.00491	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00275	0.0049	CcSEcCtD
Avanafil—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00273	0.00485	CcSEcCtD
Avanafil—Blood bilirubin increased—Citalopram—alcohol dependence	0.00273	0.00485	CcSEcCtD
Avanafil—PDE5A—blood—alcohol dependence	0.00271	0.0814	CbGeAlD
Avanafil—Influenza—Acamprosate—alcohol dependence	0.0027	0.0048	CcSEcCtD
Avanafil—Fatigue—Disulfiram—alcohol dependence	0.00269	0.00478	CcSEcCtD
Avanafil—Nasopharyngitis—Naltrexone—alcohol dependence	0.00264	0.0047	CcSEcCtD
Avanafil—Angina pectoris—Acamprosate—alcohol dependence	0.00263	0.00467	CcSEcCtD
Avanafil—Musculoskeletal pain—Citalopram—alcohol dependence	0.00261	0.00464	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00261	0.00463	CcSEcCtD
Avanafil—Bronchitis—Acamprosate—alcohol dependence	0.0026	0.00461	CcSEcCtD
Avanafil—Blood pressure increased—Citalopram—alcohol dependence	0.00258	0.00459	CcSEcCtD
Avanafil—Influenza—Naltrexone—alcohol dependence	0.00255	0.00454	CcSEcCtD
Avanafil—Wheezing—Citalopram—alcohol dependence	0.0025	0.00445	CcSEcCtD
Avanafil—Influenza like illness—Citalopram—alcohol dependence	0.0025	0.00445	CcSEcCtD
Avanafil—Pollakiuria—Acamprosate—alcohol dependence	0.00249	0.00443	CcSEcCtD
Avanafil—Angina pectoris—Naltrexone—alcohol dependence	0.00249	0.00442	CcSEcCtD
Avanafil—Weight increased—Acamprosate—alcohol dependence	0.00246	0.00437	CcSEcCtD
Avanafil—Bronchitis—Naltrexone—alcohol dependence	0.00246	0.00437	CcSEcCtD
Avanafil—Abdominal discomfort—Naltrexone—alcohol dependence	0.00245	0.00435	CcSEcCtD
Avanafil—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00237	0.00422	CcSEcCtD
Avanafil—PDE5A—endocrine gland—alcohol dependence	0.00235	0.0706	CbGeAlD
Avanafil—Urinary tract infection—Acamprosate—alcohol dependence	0.00234	0.00416	CcSEcCtD
Avanafil—Weight increased—Naltrexone—alcohol dependence	0.00232	0.00413	CcSEcCtD
Avanafil—Haematuria—Acamprosate—alcohol dependence	0.00229	0.00408	CcSEcCtD
Avanafil—Infestation—Naltrexone—alcohol dependence	0.00228	0.00405	CcSEcCtD
Avanafil—Infestation NOS—Naltrexone—alcohol dependence	0.00228	0.00405	CcSEcCtD
Avanafil—Epistaxis—Acamprosate—alcohol dependence	0.00227	0.00404	CcSEcCtD
Avanafil—PDE5A—testis—alcohol dependence	0.00224	0.0674	CbGeAlD
Avanafil—Asthenia—Disulfiram—alcohol dependence	0.00224	0.00397	CcSEcCtD
Avanafil—Urinary tract infection—Naltrexone—alcohol dependence	0.00221	0.00393	CcSEcCtD
Avanafil—PDE5A—nervous system—alcohol dependence	0.0022	0.0661	CbGeAlD
Avanafil—Diabetes mellitus—Citalopram—alcohol dependence	0.00215	0.00383	CcSEcCtD
Avanafil—Epistaxis—Naltrexone—alcohol dependence	0.00215	0.00382	CcSEcCtD
Avanafil—Sinusitis—Naltrexone—alcohol dependence	0.00214	0.0038	CcSEcCtD
Avanafil—Oedema peripheral—Acamprosate—alcohol dependence	0.00213	0.00378	CcSEcCtD
Avanafil—PDE5A—central nervous system—alcohol dependence	0.00212	0.0637	CbGeAlD
Avanafil—PDE5A—cerebellum—alcohol dependence	0.00207	0.0622	CbGeAlD
Avanafil—Dizziness—Disulfiram—alcohol dependence	0.00206	0.00366	CcSEcCtD
Avanafil—Nasal congestion—Citalopram—alcohol dependence	0.00206	0.00365	CcSEcCtD
Avanafil—Connective tissue disorder—Naltrexone—alcohol dependence	0.00201	0.00357	CcSEcCtD
Avanafil—Hot flush—Citalopram—alcohol dependence	0.002	0.00356	CcSEcCtD
Avanafil—Menopausal symptoms—Citalopram—alcohol dependence	0.00198	0.00353	CcSEcCtD
Avanafil—Rash—Disulfiram—alcohol dependence	0.00196	0.00349	CcSEcCtD
Avanafil—Headache—Disulfiram—alcohol dependence	0.00195	0.00347	CcSEcCtD
Avanafil—Immune system disorder—Acamprosate—alcohol dependence	0.00195	0.00347	CcSEcCtD
Avanafil—Hypoglycaemia—Citalopram—alcohol dependence	0.00192	0.00341	CcSEcCtD
Avanafil—Eye disorder—Naltrexone—alcohol dependence	0.00191	0.0034	CcSEcCtD
Avanafil—Cardiac disorder—Naltrexone—alcohol dependence	0.0019	0.00337	CcSEcCtD
Avanafil—Mental disorder—Acamprosate—alcohol dependence	0.00189	0.00336	CcSEcCtD
Avanafil—Malnutrition—Acamprosate—alcohol dependence	0.00188	0.00334	CcSEcCtD
Avanafil—Pain in extremity—Citalopram—alcohol dependence	0.00187	0.00333	CcSEcCtD
Avanafil—Angiopathy—Naltrexone—alcohol dependence	0.00185	0.0033	CcSEcCtD
Avanafil—Immune system disorder—Naltrexone—alcohol dependence	0.00185	0.00328	CcSEcCtD
Avanafil—Mediastinal disorder—Naltrexone—alcohol dependence	0.00184	0.00327	CcSEcCtD
Avanafil—Back pain—Acamprosate—alcohol dependence	0.00182	0.00323	CcSEcCtD
Avanafil—Muscle spasms—Acamprosate—alcohol dependence	0.00181	0.00321	CcSEcCtD
Avanafil—Mental disorder—Naltrexone—alcohol dependence	0.00179	0.00318	CcSEcCtD
Avanafil—Malnutrition—Naltrexone—alcohol dependence	0.00178	0.00316	CcSEcCtD
Avanafil—Agitation—Acamprosate—alcohol dependence	0.00173	0.00307	CcSEcCtD
Avanafil—Back pain—Naltrexone—alcohol dependence	0.00172	0.00306	CcSEcCtD
Avanafil—Muscle spasms—Naltrexone—alcohol dependence	0.00171	0.00304	CcSEcCtD
Avanafil—Breast disorder—Citalopram—alcohol dependence	0.00169	0.00301	CcSEcCtD
Avanafil—Vertigo—Acamprosate—alcohol dependence	0.00169	0.003	CcSEcCtD
Avanafil—PDE5A—brain—alcohol dependence	0.00168	0.0505	CbGeAlD
Avanafil—Vision blurred—Naltrexone—alcohol dependence	0.00168	0.00298	CcSEcCtD
Avanafil—Nasopharyngitis—Citalopram—alcohol dependence	0.00167	0.00298	CcSEcCtD
Avanafil—Palpitations—Acamprosate—alcohol dependence	0.00166	0.00295	CcSEcCtD
Avanafil—Gastritis—Citalopram—alcohol dependence	0.00166	0.00295	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00165	0.00294	CcSEcCtD
Avanafil—Cough—Acamprosate—alcohol dependence	0.00164	0.00292	CcSEcCtD
Avanafil—Agitation—Naltrexone—alcohol dependence	0.00164	0.00291	CcSEcCtD
Avanafil—Hypertension—Acamprosate—alcohol dependence	0.00162	0.00289	CcSEcCtD
Avanafil—Influenza—Citalopram—alcohol dependence	0.00162	0.00288	CcSEcCtD
Avanafil—Chest pain—Acamprosate—alcohol dependence	0.0016	0.00285	CcSEcCtD
Avanafil—Myalgia—Acamprosate—alcohol dependence	0.0016	0.00285	CcSEcCtD
Avanafil—Arthralgia—Acamprosate—alcohol dependence	0.0016	0.00285	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00159	0.00283	CcSEcCtD
Avanafil—Angina pectoris—Citalopram—alcohol dependence	0.00158	0.0028	CcSEcCtD
Avanafil—Palpitations—Naltrexone—alcohol dependence	0.00157	0.0028	CcSEcCtD
Avanafil—Dry mouth—Acamprosate—alcohol dependence	0.00157	0.00278	CcSEcCtD
Avanafil—Bronchitis—Citalopram—alcohol dependence	0.00156	0.00277	CcSEcCtD
Avanafil—Cough—Naltrexone—alcohol dependence	0.00155	0.00276	CcSEcCtD
Avanafil—Abdominal discomfort—Citalopram—alcohol dependence	0.00155	0.00276	CcSEcCtD
Avanafil—Hypertension—Naltrexone—alcohol dependence	0.00154	0.00273	CcSEcCtD
Avanafil—Infection—Acamprosate—alcohol dependence	0.00153	0.00271	CcSEcCtD
Avanafil—Myalgia—Naltrexone—alcohol dependence	0.00152	0.00269	CcSEcCtD
Avanafil—Arthralgia—Naltrexone—alcohol dependence	0.00152	0.00269	CcSEcCtD
Avanafil—Chest pain—Naltrexone—alcohol dependence	0.00152	0.00269	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.0015	0.00267	CcSEcCtD
Avanafil—Upper respiratory tract infection—Citalopram—alcohol dependence	0.0015	0.00267	CcSEcCtD
Avanafil—Tachycardia—Acamprosate—alcohol dependence	0.0015	0.00266	CcSEcCtD
Avanafil—Pollakiuria—Citalopram—alcohol dependence	0.00149	0.00266	CcSEcCtD
Avanafil—Skin disorder—Acamprosate—alcohol dependence	0.00149	0.00265	CcSEcCtD
Avanafil—Dry mouth—Naltrexone—alcohol dependence	0.00148	0.00263	CcSEcCtD
Avanafil—Weight increased—Citalopram—alcohol dependence	0.00147	0.00262	CcSEcCtD
Avanafil—Infection—Naltrexone—alcohol dependence	0.00144	0.00256	CcSEcCtD
Avanafil—Infestation NOS—Citalopram—alcohol dependence	0.00144	0.00256	CcSEcCtD
Avanafil—Infestation—Citalopram—alcohol dependence	0.00144	0.00256	CcSEcCtD
Avanafil—Hypotension—Acamprosate—alcohol dependence	0.00143	0.00255	CcSEcCtD
Avanafil—Nervous system disorder—Naltrexone—alcohol dependence	0.00142	0.00253	CcSEcCtD
Avanafil—Tachycardia—Naltrexone—alcohol dependence	0.00142	0.00252	CcSEcCtD
Avanafil—Skin disorder—Naltrexone—alcohol dependence	0.00141	0.00251	CcSEcCtD
Avanafil—Urinary tract infection—Citalopram—alcohol dependence	0.0014	0.00249	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.0014	0.00249	CcSEcCtD
Avanafil—Insomnia—Acamprosate—alcohol dependence	0.00139	0.00247	CcSEcCtD
Avanafil—Haematuria—Citalopram—alcohol dependence	0.00138	0.00245	CcSEcCtD
Avanafil—Somnolence—Acamprosate—alcohol dependence	0.00136	0.00243	CcSEcCtD
Avanafil—Epistaxis—Citalopram—alcohol dependence	0.00136	0.00242	CcSEcCtD
Avanafil—Sinusitis—Citalopram—alcohol dependence	0.00135	0.00241	CcSEcCtD
Avanafil—Dyspepsia—Acamprosate—alcohol dependence	0.00135	0.0024	CcSEcCtD
Avanafil—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00133	0.00236	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00132	0.00235	CcSEcCtD
Avanafil—Insomnia—Naltrexone—alcohol dependence	0.00131	0.00234	CcSEcCtD
Avanafil—Constipation—Acamprosate—alcohol dependence	0.00131	0.00233	CcSEcCtD
Avanafil—Somnolence—Naltrexone—alcohol dependence	0.00129	0.0023	CcSEcCtD
Avanafil—Urinary tract disorder—Citalopram—alcohol dependence	0.00128	0.00227	CcSEcCtD
Avanafil—Oedema peripheral—Citalopram—alcohol dependence	0.00128	0.00227	CcSEcCtD
Avanafil—Connective tissue disorder—Citalopram—alcohol dependence	0.00127	0.00226	CcSEcCtD
Avanafil—Urethral disorder—Citalopram—alcohol dependence	0.00127	0.00226	CcSEcCtD
Avanafil—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00125	0.00223	CcSEcCtD
Avanafil—Fatigue—Naltrexone—alcohol dependence	0.00125	0.00223	CcSEcCtD
Avanafil—Constipation—Naltrexone—alcohol dependence	0.00124	0.00221	CcSEcCtD
Avanafil—Body temperature increased—Acamprosate—alcohol dependence	0.00121	0.00216	CcSEcCtD
Avanafil—Eye disorder—Citalopram—alcohol dependence	0.00121	0.00215	CcSEcCtD
Avanafil—Cardiac disorder—Citalopram—alcohol dependence	0.0012	0.00214	CcSEcCtD
Avanafil—Flushing—Citalopram—alcohol dependence	0.0012	0.00214	CcSEcCtD
Avanafil—Angiopathy—Citalopram—alcohol dependence	0.00118	0.00209	CcSEcCtD
Avanafil—Immune system disorder—Citalopram—alcohol dependence	0.00117	0.00208	CcSEcCtD
Avanafil—Mediastinal disorder—Citalopram—alcohol dependence	0.00117	0.00208	CcSEcCtD
Avanafil—Body temperature increased—Naltrexone—alcohol dependence	0.00115	0.00204	CcSEcCtD
Avanafil—Mental disorder—Citalopram—alcohol dependence	0.00113	0.00202	CcSEcCtD
Avanafil—Malnutrition—Citalopram—alcohol dependence	0.00113	0.002	CcSEcCtD
Avanafil—Asthenia—Acamprosate—alcohol dependence	0.0011	0.00196	CcSEcCtD
Avanafil—Back pain—Citalopram—alcohol dependence	0.00109	0.00194	CcSEcCtD
Avanafil—Pruritus—Acamprosate—alcohol dependence	0.00109	0.00193	CcSEcCtD
Avanafil—Muscle spasms—Citalopram—alcohol dependence	0.00108	0.00193	CcSEcCtD
Avanafil—Vision blurred—Citalopram—alcohol dependence	0.00106	0.00189	CcSEcCtD
Avanafil—Diarrhoea—Acamprosate—alcohol dependence	0.00105	0.00187	CcSEcCtD
Avanafil—Asthenia—Naltrexone—alcohol dependence	0.00104	0.00185	CcSEcCtD
Avanafil—Agitation—Citalopram—alcohol dependence	0.00104	0.00184	CcSEcCtD
Avanafil—Pruritus—Naltrexone—alcohol dependence	0.00103	0.00183	CcSEcCtD
Avanafil—Dizziness—Acamprosate—alcohol dependence	0.00102	0.0018	CcSEcCtD
Avanafil—Vertigo—Citalopram—alcohol dependence	0.00101	0.0018	CcSEcCtD
Avanafil—Palpitations—Citalopram—alcohol dependence	0.000996	0.00177	CcSEcCtD
Avanafil—Diarrhoea—Naltrexone—alcohol dependence	0.000994	0.00177	CcSEcCtD
Avanafil—Cough—Citalopram—alcohol dependence	0.000984	0.00175	CcSEcCtD
Avanafil—Vomiting—Acamprosate—alcohol dependence	0.000976	0.00173	CcSEcCtD
Avanafil—Hypertension—Citalopram—alcohol dependence	0.000973	0.00173	CcSEcCtD
Avanafil—Rash—Acamprosate—alcohol dependence	0.000968	0.00172	CcSEcCtD
Avanafil—Dermatitis—Acamprosate—alcohol dependence	0.000967	0.00172	CcSEcCtD
Avanafil—Headache—Acamprosate—alcohol dependence	0.000962	0.00171	CcSEcCtD
Avanafil—Dizziness—Naltrexone—alcohol dependence	0.00096	0.00171	CcSEcCtD
Avanafil—Myalgia—Citalopram—alcohol dependence	0.00096	0.00171	CcSEcCtD
Avanafil—Arthralgia—Citalopram—alcohol dependence	0.00096	0.00171	CcSEcCtD
Avanafil—Chest pain—Citalopram—alcohol dependence	0.00096	0.00171	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000953	0.00169	CcSEcCtD
Avanafil—Dry mouth—Citalopram—alcohol dependence	0.000939	0.00167	CcSEcCtD
Avanafil—Vomiting—Naltrexone—alcohol dependence	0.000923	0.00164	CcSEcCtD
Avanafil—Rash—Naltrexone—alcohol dependence	0.000916	0.00163	CcSEcCtD
Avanafil—Dermatitis—Naltrexone—alcohol dependence	0.000915	0.00163	CcSEcCtD
Avanafil—Infection—Citalopram—alcohol dependence	0.000914	0.00163	CcSEcCtD
Avanafil—Nausea—Acamprosate—alcohol dependence	0.000912	0.00162	CcSEcCtD
Avanafil—Headache—Naltrexone—alcohol dependence	0.00091	0.00162	CcSEcCtD
Avanafil—Nervous system disorder—Citalopram—alcohol dependence	0.000902	0.0016	CcSEcCtD
Avanafil—Tachycardia—Citalopram—alcohol dependence	0.000898	0.0016	CcSEcCtD
Avanafil—Skin disorder—Citalopram—alcohol dependence	0.000894	0.00159	CcSEcCtD
Avanafil—CYP3A4—digestive system—alcohol dependence	0.000888	0.0267	CbGeAlD
Avanafil—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.000868	0.14	CbGpPWpGaD
Avanafil—Nausea—Naltrexone—alcohol dependence	0.000863	0.00153	CcSEcCtD
Avanafil—Hypotension—Citalopram—alcohol dependence	0.00086	0.00153	CcSEcCtD
Avanafil—CYP3A4—blood—alcohol dependence	0.000846	0.0254	CbGeAlD
Avanafil—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000838	0.00149	CcSEcCtD
Avanafil—Insomnia—Citalopram—alcohol dependence	0.000832	0.00148	CcSEcCtD
Avanafil—Somnolence—Citalopram—alcohol dependence	0.000818	0.00145	CcSEcCtD
Avanafil—Dyspepsia—Citalopram—alcohol dependence	0.00081	0.00144	CcSEcCtD
Avanafil—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000794	0.00141	CcSEcCtD
Avanafil—Fatigue—Citalopram—alcohol dependence	0.000793	0.00141	CcSEcCtD
Avanafil—Constipation—Citalopram—alcohol dependence	0.000787	0.0014	CcSEcCtD
Avanafil—CYP3A4—endocrine gland—alcohol dependence	0.000733	0.022	CbGeAlD
Avanafil—Body temperature increased—Citalopram—alcohol dependence	0.000727	0.00129	CcSEcCtD
Avanafil—CYP3A4—nervous system—alcohol dependence	0.000687	0.0206	CbGeAlD
Avanafil—CYP3A4—liver—alcohol dependence	0.000661	0.0199	CbGeAlD
Avanafil—CYP3A4—central nervous system—alcohol dependence	0.000661	0.0198	CbGeAlD
Avanafil—Asthenia—Citalopram—alcohol dependence	0.00066	0.00117	CcSEcCtD
Avanafil—Pruritus—Citalopram—alcohol dependence	0.000651	0.00116	CcSEcCtD
Avanafil—Diarrhoea—Citalopram—alcohol dependence	0.00063	0.00112	CcSEcCtD
Avanafil—Dizziness—Citalopram—alcohol dependence	0.000609	0.00108	CcSEcCtD
Avanafil—Vomiting—Citalopram—alcohol dependence	0.000585	0.00104	CcSEcCtD
Avanafil—Rash—Citalopram—alcohol dependence	0.00058	0.00103	CcSEcCtD
Avanafil—Dermatitis—Citalopram—alcohol dependence	0.00058	0.00103	CcSEcCtD
Avanafil—Headache—Citalopram—alcohol dependence	0.000577	0.00102	CcSEcCtD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.000556	0.0896	CbGpPWpGaD
Avanafil—Nausea—Citalopram—alcohol dependence	0.000547	0.000972	CcSEcCtD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.000461	0.0742	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.000392	0.0631	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.000333	0.0537	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.000293	0.0472	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.000292	0.047	CbGpPWpGaD
Avanafil—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.000278	0.0448	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000206	0.0331	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000165	0.0265	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000157	0.0252	CbGpPWpGaD
Avanafil—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000138	0.0222	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000132	0.0213	CbGpPWpGaD
Avanafil—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000132	0.0212	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00013	0.0209	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00011	0.0178	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000104	0.0167	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	9.38e-05	0.0151	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	9e-05	0.0145	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	8.84e-05	0.0142	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH6—alcohol dependence	8.32e-05	0.0134	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	8.23e-05	0.0132	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	7.07e-05	0.0114	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	6.89e-05	0.0111	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	6.82e-05	0.011	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH4—alcohol dependence	5.86e-05	0.00944	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	5.8e-05	0.00933	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	5.72e-05	0.0092	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	5.64e-05	0.00908	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH7—alcohol dependence	4.98e-05	0.00803	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GGT2—alcohol dependence	4.78e-05	0.00769	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	4.63e-05	0.00746	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	4.37e-05	0.00704	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—EP300—alcohol dependence	3.93e-05	0.00633	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	3.81e-05	0.00614	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—MAOB—alcohol dependence	3.62e-05	0.00583	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	3.08e-05	0.00496	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	3.06e-05	0.00493	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.48e-05	0.004	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	2.46e-05	0.00396	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	2.43e-05	0.00391	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GGT1—alcohol dependence	2.26e-05	0.00364	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—MAOA—alcohol dependence	2.02e-05	0.00326	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH6—alcohol dependence	1.42e-05	0.00229	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.32e-05	0.00212	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.18e-05	0.0019	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH4—alcohol dependence	1e-05	0.00161	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH7—alcohol dependence	8.52e-06	0.00137	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GGT2—alcohol dependence	8.17e-06	0.00132	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH1B—alcohol dependence	7.47e-06	0.0012	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MAOB—alcohol dependence	6.19e-06	0.000997	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH2—alcohol dependence	5.26e-06	0.000848	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT2—alcohol dependence	4.48e-06	0.000721	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP2E1—alcohol dependence	4.21e-06	0.000678	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GGT1—alcohol dependence	3.86e-06	0.000622	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT1—alcohol dependence	3.86e-06	0.000622	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MAOA—alcohol dependence	3.46e-06	0.000558	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—POMC—alcohol dependence	2.25e-06	0.000363	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—EP300—alcohol dependence	1.5e-06	0.000241	CbGpPWpGaD
